Active Pharmaceutical Ingredient (API) consultants are pivotal in navigating the complexities of drug manufacturing and regulatory compliance in pharmaceutical development…
In the ever-evolving world of pharmaceuticals, Olon continues to push the boundaries of what’s possible. We’re excited to introduce a…
It has been an outstanding CPHI for Olon, it achieved an incredible success at 2023 Global Generic and Biosimilar Awards…
On the occasion of CPhI Worldwide 2023 (Barcelona, 24 – 26 Oct), the most important international event of the chemical-pharmaceutical…
Olon, global leader in the development and production of active pharmaceutical ingredients (APIs) for CDMO and generic markets, integrating chemical…
Olon is pleased to announce the completion of the investment in its Rodano facility to expand the pilot plant capacity…
Milan – Italy, February 20, 2023 – Olon Group and the Politecnico di Milano, Department of Chemistry, Materials and Chemical…